How would you treat gray zone lymphoma which initially achieved a CR after 2 cycles of DA-R-EPOCH, but end-of-treatment PET demonstrates progression with new sites of biopsy-proven disease?

Topics: Hematologic Malignancies • Medical Oncology • Bone Marrow Transplant • Lymphoma • NCI-CCC Tumor Board Question • Hematology • Memorial Sloan Kettering • NCI-CCC Lymphoma Tumor Board Question

Answer from: at Community Practice

While admittedly the (non randomized) data comes from HL, would consider pembro-GDP vs BV/nivo with the plan to go to auto.

Comments

Medical Oncologist at Rutgers Cancer Institute of New Jersey
We’d gone with BV+nivo towards auto - glad t...

Related Questions